Drug and Device Development

The Stanford Maternal and Child Health Research Institute is dedicated  to guiding Stanford investigators in the maturation of breakthrough therapies through proof-of-concept studies and commercialization.

Drug and Device Development Service

The Drug and Device Development Service exists to advance cutting edge therapies and technologies generated by the Stanford community to benefit the advancement of care to mothers and children.


MCHRI supports investigators with streamlining product development, reducing risk and increasing valuation, including:

Regulatory Strategy
Target Profile Development
Path from Bench to Bedside

Market Assessment
Existing/Competing Solutions
Market Sizing and Clinical Impact

Project Management
Timeline Development
Budget Building/Tracking

Click here to learn more>>


MCHRI guides health innovations through the regulatory and medical development landscapes, including:

Regulatory Interactions
IND/IDE Preparation and Maintenance

Funding Opportunities
Exploration and Evaluation

Business Development
Engagement with VC and Industry

Click here to learn more>>


MCHRI designs and coordinates educational opportunities to benefit translational medicine scientists at Stanford, featuring:

Career Development
Eureka Certificate Course in Translational Medicine

Drug & Device Development (D3) Training

Topic Discussions
Webinars and Live Presentations


Grant Wells, MS
Director of Innovation & Development